This study is a prospective, observational study of changing from any IOP-lowering treatment to a prostaglandin analogue-containing IOP-lowering medication for patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT). The decision to change medications lies with the physician according to their standard practice.
Study Type
OBSERVATIONAL
Enrollment
358
Patients with POAG or OHT on current IOP-lowering therapy who are prescribed a prostaglandin analogue -containing IOP-lowering therapy by the physician. The decision to prescribe a change in IOP-lowering therapy lies with the physician according to their standard practice.
Unnamed facility
Istanbul, Turkey (Türkiye)
Change From Baseline in Intraocular Pressure (IOP) in the Right Eye
IOP is a measurement of the fluid pressure inside the eye. A negative change from Baseline indicates an improvement.
Time frame: Baseline, Week 12
Change From Baseline in Intraocular Pressure (IOP) in the Left Eye
IOP is a measurement of the fluid pressure inside the eye. A negative change from Baseline indicates an improvement.
Time frame: Baseline, Week 12
Patient Assessment of Overall Tolerability With New Treatment Using a 4-Point Scale
The patient evaluated the tolerability of IOP-lowering medication therapy using a 4-Point Scale: Very good, Good, Moderate or Poor. Percentage of participants in each category is reported.
Time frame: 12 Weeks
Physician Assessment of Tolerability With New Treatment Using a 4-Point Scale
The physician evaluated the patient's tolerability of IOP-lowering medication therapy using a 4-Point Scale: Very good, Good, Moderate or Poor. Percentage of participants in each category is reported.
Time frame: 12 Weeks
Percentage of Participants Who Discontinue the Use of New Treatment Prior to 12 Weeks
Time frame: 12 Weeks
Percentage of Participants Who Continue the New Treatment After 12 Weeks
Time frame: 12 Weeks
Physician Assessment of Adherence to New Treatment Using a 4-Point Scale
The physician assessed the participant's adherence to new treatment using the following scale: Not Applicable, Worse, Equal or Better. The percentage of participants in each category is reported.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12 Weeks
Physician Assessment of Efficacy Using a 5-Point Scale
The physician evaluated efficacy (IOP lowering) using a 5-Point Scale: IOP lower than target, Reached Target IOP, IOP decreased but target not reached, No change or IOP increased. The percentage of participants in each category is reported.
Time frame: 12 Weeks
Percentage of Participants Reaching Individual IOP Target After 12 Weeks
Time frame: 12 Weeks